CYBR

COM:CYBREXA

Cybrexa Therapeutics

  • Privately Held

Cybrexa Therapeutics develops a new class of therapeutics that targets the tumor microenvironment for cancer treatment, utilizing proprietary technology for drug delivery directly into tumor cells. Self-described as pioneering and focused on oncology.

competitor of